These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 18491370)
1. Inhibitory effects of nordihydroguaiaretic acid (NDGA) on the IGF-1 receptor and androgen dependent growth of LAPC-4 prostate cancer cells. Ryan CJ; Zavodovskaya M; Youngren JF; Campbell M; Diamond M; Jones J; Shiry L; Allan G; Maddux BA; Goldfine ID Prostate; 2008 Aug; 68(11):1232-40. PubMed ID: 18491370 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
3. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors. Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471 [TBL] [Abstract][Full Text] [Related]
4. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells. Zavodovskaya M; Campbell MJ; Maddux BA; Shiry L; Allan G; Hodges L; Kushner P; Kerner JA; Youngren JF; Goldfine ID J Cell Biochem; 2008 Feb; 103(2):624-35. PubMed ID: 17562544 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway. Jang YG; Go RE; Hwang KA; Choi KC J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279 [TBL] [Abstract][Full Text] [Related]
6. Regulation of androgen receptor by androgen and epidermal growth factor in a human prostatic cancer cell line, LNCaP. Mizokami A; Saiga H; Matsui T; Mita T; Sugita A Endocrinol Jpn; 1992 Jun; 39(3):235-43. PubMed ID: 1425449 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs. Blecha JE; Anderson MO; Chow JM; Guevarra CC; Pender C; Penaranda C; Zavodovskaya M; Youngren JF; Berkman CE Bioorg Med Chem Lett; 2007 Jul; 17(14):4026-9. PubMed ID: 17502145 [TBL] [Abstract][Full Text] [Related]
8. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741 [TBL] [Abstract][Full Text] [Related]
9. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells. Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383 [TBL] [Abstract][Full Text] [Related]
10. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Youngren JF; Gable K; Penaranda C; Maddux BA; Zavodovskaya M; Lobo M; Campbell M; Kerner J; Goldfine ID Breast Cancer Res Treat; 2005 Nov; 94(1):37-46. PubMed ID: 16142439 [TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells. Zhang PJ; Hu XY; Liu CY; Chen ZB; Ni NN; Yu Y; Yang LN; Huang ZQ; Liu QW; Jiang AL Asian J Androl; 2012 May; 14(3):493-8. PubMed ID: 22179513 [TBL] [Abstract][Full Text] [Related]
12. Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor. Kato H; Sekine Y; Furuya Y; Miyazawa Y; Koike H; Suzuki K Biochem Biophys Res Commun; 2015 May; 461(1):115-21. PubMed ID: 25862373 [TBL] [Abstract][Full Text] [Related]
13. A novel synthetic compound that interrupts androgen receptor signaling in human prostate cancer cells. Lu S; Wang A; Lu S; Dong Z Mol Cancer Ther; 2007 Jul; 6(7):2057-64. PubMed ID: 17620434 [TBL] [Abstract][Full Text] [Related]
14. 17alpha-estradiol inhibits LAPC-4 prostatic tumor cell proliferation in cell cultures and tumor growth in xenograft animals. Qiao Y; Zhang ZK; Cai LQ; Tan C; Imperato-McGinley JL; Zhu YS Prostate; 2007 Dec; 67(16):1719-28. PubMed ID: 17879940 [TBL] [Abstract][Full Text] [Related]
15. Differential posttranscriptional regulation of androgen receptor gene expression by androgen in prostate and breast cancer cells. Yeap BB; Krueger RG; Leedman PJ Endocrinology; 1999 Jul; 140(7):3282-91. PubMed ID: 10385425 [TBL] [Abstract][Full Text] [Related]
16. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells. Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of estrogen receptor ligands on regulation of dihydrotestosterone-induced cell proliferation in endothelial and prostate cancer cells. Weng C; Cai J; Wen J; Yuan H; Yang K; Imperato-McGinley J; Zhu YS Int J Oncol; 2013 Jan; 42(1):327-37. PubMed ID: 23135751 [TBL] [Abstract][Full Text] [Related]
18. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells. Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946 [TBL] [Abstract][Full Text] [Related]
19. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364 [TBL] [Abstract][Full Text] [Related]
20. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Le H; Arnold JT; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]